Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →15
🟡 Moderate
🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,287
Total Claims
$967K
Drug Cost
525
Beneficiaries
$1,842
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+25%
Opioid rate vs peers
3.1% vs 2.5% avg
+63%
Cost per patient vs peers
$1,842 vs $1,128 avg
+30%
Brand preference vs peers
11.0% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.1%
Opioid Rate
287
Opioid Claims
$13K
Opioid Cost
8.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,011 claims · $708K
Generic: 8,213 claims · $256K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 86 | $87K |
| Dapagliflozin Propanediol | 53 | $84K |
| Empagliflozin | 54 | $73K |
| Sitagliptin Phosphate | 34 | $49K |
| Icosapent Ethyl | 46 | $44K |
| Semaglutide | 29 | $38K |
| Rivaroxaban | 36 | $33K |
| Dulaglutide | 23 | $31K |
| Insulin Lispro | 22 | $23K |
| Sitagliptin Phos/Metformin Hcl | 13 | $21K |
| Fluticasone/Umeclidin/Vilanter | 15 | $20K |
| Budesonide/Glycopyr/Formoterol | 14 | $18K |
| Ezetimibe | 310 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $13K |
| Rosuvastatin Calcium | 411 | $12K |
Prescribing Profile
Patient Profile
74
Avg Age
54%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About